Ralliant Corp. <RAL.N>: Oppenheimer raises target price to $80 from $75
RAL•Related News
Myriad Genetics, Inc. <MYGN.O>: UBS Cuts Target Price to $3.6 From $6
MYGN•
Iran and US hit tankers in biggest wave of attacks on shipping since war began
XLE•
SLB N.V. <SLB.N>: UBS Raises Target Price To $72 From $66
SLB•
Kratos says ARAV-B ballistic missile target completes Pacific Dragon 2026 mission
KTOS•
AIM ImmunoTech advances Phase 2 DURIPANC trial of Ampligen plus AstraZeneca’s Imfinzi in pancreatic cancer
AIM•